EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

AICyte‐alone capabilities as an independent screener for triaging cervical cytology using a 50% negative cutoff value

Xianxu Zeng, David Starr, Juan Li, Xuejie Bi, Chun Wang, Xinru Bai, Yanxue Yin, Xue Wu, Jingjing Wei, Hui Du, Wenkui Dai, Changzhong Li und 3 weitere

Cancer Cytopathology · 2024

DOI: 10.1002/cncy.22896 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cytopathology, 2024. Verfasst von Xianxu Zeng und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Vaginal Smears. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Science and Technology Development Plan of Henan Province, Shenzhen Science and Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

AICyte has previously demonstrated a potential role in cervical cytology screening for reducing the workload by using a 50% negative cutoff value. The aim of the current study is to evaluate this hypothesis.

Methods

The authors used the Ruiqian WSI‐2400 (with the registered trademark AICyte) to evaluate a collection of 163,848 original cervical cytology cases from 2018 to 2023 that were collected from four different hospital systems in China. A breakdown of cases included 46,060 from Shenzhen, 67,472 from Zhengzhou, 25,667 from Shijiazhuang, and 24,649 from Jinan. These collected cases were evaluated using the AICyte system, and the data collected were statistically compared with the original interpretative results.

Results

In 98.80% of all artificial intelligence cases that were designated as not needing further review, the corresponding original diagnosis was also determined to be negative. For any cases that were designated atypical squamous cells, cannot exclude high‐grade squamous intraepithelial lesion or higher, the sensitivity and negative predictive value were 90.77% and 98.80%, respectively. The sensitivity and negative predictive value were greater in cases designated as low‐grade squamous intraepithelial lesion or higher at 98.92% and 99.94%, respectively. Of the 49 low‐grade squamous intraepithelial lesion or higher that were designed by AICyte as not needing further review, the cytohistologic correlation revealed eight cases of cervical intraepithelial neoplasia 1 and 18 negative cases; and the remaining cases were without histologic follow‐up. In practice, AICyte used at a 50% negative cutoff value could reduce the anticipated workload if a protocol were implemented to label cases that qualified within the negative cutoff value as not needing further review, thereby finalizing the case as negative for intraepithelial lesions and malignancy.

Conclusions

For pathologic practices that do not have cytotechnologists or in which the workflow is sought to be optimized, the artificial intelligence system AICyte alone to be an independent screening tool by using a 50% negative cutoff value, which is a potential assistive method for cervical cancer screening.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsVaginal SmearsHumansFemaleEarly Detection of CancerMiddle AgedArtificial IntelligenceAdultTriageUterine Cervical DysplasiaAtypical Squamous Cells of the CervixChinaPredictive Value of TestsSensitivity and Specificity

Stichwörter der Autor:innen

artificial intelligenceautomationcervical screeningcytopathology

Autor:innen und Institutionen

  • Department of Pathology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Zhengzhou Key Laboratory of Gynecological Disease's Early Diagnosis, Zhengzhou, China.
  • Department of Pathology, Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Department of Pathology, Jinan Maternity and Child Care Hospital, Jinan, Shandong, China.
  • Department of Pathology, Shijiazhuang Maternity and Child Care Hospital, Shijiazhuang, Hebei, China.
  • Department of Obstetrics and Gynecology, Peking University Shenzhen Hospital, Shenzhen, China.

ORCID-Profile: Chengquan Zhao

Förderung

  • Science and Technology Development Plan of Henan Province
  • Shenzhen Science and Technology Project

Zitieren

APA

Zeng, X., Starr, D., Li, J., Bi, X., Wang, C., Bai, X., Yin, Y., Wu, X., Wei, J., Du, H., Dai, W., Li, C., Wu, X., Wu, R., & Zhao, C. (2024). AICyte‐alone capabilities as an independent screener for triaging cervical cytology using a 50% negative cutoff value. Cancer Cytopathology. https://doi.org/10.1002/cncy.22896

Vancouver

Zeng X, Starr D, Li J, Bi X, Wang C, Bai X, et al. AICyte‐alone capabilities as an independent screener for triaging cervical cytology using a 50% negative cutoff value. Cancer Cytopathology. 2024. doi:10.1002/cncy.22896

BibTeX
@article{Zeng2024,
  author = {Zeng, Xianxu and Starr, David and Li, Juan and Bi, Xuejie and Wang, Chun and Bai, Xinru and Yin, Yanxue and Wu, Xue and Wei, Jingjing and Du, Hui and Dai, Wenkui and Li, Changzhong and Wu, Xiangchen and Wu, Ruifang and Zhao, Chengquan},
  title = {AICyte‐alone capabilities as an independent screener for triaging cervical cytology using a 50% negative cutoff value},
  journal = {Cancer Cytopathology},
  year = {2024},
  doi = {10.1002/cncy.22896}
}
Kostenlos starten →